Thomas Van Der Does

Title: Thomas Van Der Does: Innovator in Cyclopeptide and Penicillin G Acylase Technologies

Introduction

Thomas Van Der Does is a notable inventor based in Wilnis, Netherlands. He has made significant contributions to the field of biochemistry, particularly in the development of cyclopeptides and mutant penicillin G acylases. With a total of four patents to his name, his work has implications for pharmaceutical advancements.

Latest Patents

One of his latest patents is a method for the preparation of cyclopeptides. This invention relates to a method for preparing cyclopeptides by means of protection with a substituted boronic acid. The patent also discloses novel boronate esters of cyclopeptides of general formula (8). Another significant patent is for mutant penicillin G acylases. This invention pertains to a mutant prokaryotic penicillin G acylase derived from a wild-type penicillin G acylase. The mutant is characterized by having an amino acid substitution at one or more specific amino acid positions.

Career Highlights

Throughout his career, Thomas has worked with prominent companies such as DSM Sinochem Pharmaceuticals Netherlands B.V. and DSM IP Assets B.V. His experience in these organizations has allowed him to further his research and development efforts in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Harold Monro Moody and Robertus Mattheus De Pater. Their collaboration has likely contributed to the innovative projects and patents that Thomas has developed over the years.

Conclusion

Thomas Van Der Does is a distinguished inventor whose work in cyclopeptides and penicillin G acylases has made a significant impact in the field of biochemistry. His patents reflect a commitment to advancing pharmaceutical technologies.